21.2 C
New York
Thursday, June 18, 2026

Tag: statements

newssourceFORcompanyinformationcontent1marketreleases

YY Group Completes US$20 Million At-The-Market Equity Offering Program

YY Group completes US$20 million ATM Program, raising approximately US$19.1 million net proceeds for AI, robotics and IFM initiatives.

OLIN and HUNTSMAN Announce Transformative Merger of Equals to Create a $12+ Billion Integrated North American Chemicals Leader

Complementary upstream and downstream capabilities to enhance integration and enable the combined company to better create value across cycles, products and regions $400+ million...

Equinor’s Capital Markets Day 2026

Equinor ASA (OSE:EQNR, NYSE:EQNR) today presents its strategy to deliver more energy, growing cash flow and superior returns. The 2026 share buy-back will be doubled to USD 3 billion, and Equinor introduces a more predictable framework for annual share buy-backs from 2027. The company aims to continue growing the quarterly cash dividend by more than 5% per share annually.

VEON’s JazzCash and Mobilink Bank Bring Government Treasury Bills to Smartphones, Democratising Investment for Millions of Pakistanis

Dubai, New York and Islamabad, June 16 2026 — VEON Ltd (Nasdaq: VEON), a global digital operator, today announced that its digital financial services companies JazzCash and Mobilink Bank have democratized investment opportunities in Pakistan by introducing Government Treasury Bills directly through the JazzCash app, starting from as little as PKR 5,000 (approx. USD 18). The initiative aims to reach one million active investors, working in coordination with the State Bank of Pakistan and the Ministry of Finance, Pakistan.

Tamarack Valley Energy Ltd. Closes Previously Announced Sale of Charlie Lake Assets

TSX: TVECALGARY, AB, June 16, 2026 /CNW/ - Tamarack Valley Energy Ltd. has successfully closed the previously announced sale of its Charlie Lake assets for...

Claret Capital Partners participates in €130m financing for Inventiva to support Phase 3 development

Claret Capital Partners is providing growth funding of €43m as part of Inventiva’s €130m debt financing, to support its lead asset through Phase 3.

Havila Kystruten AS: Trading Update May 2026

Operational Highlights May

Fiserv Announces Launch of Tender Offers for Any and All of its Outstanding 5.150% Senior Notes due 2027 and 4.400% Senior Notes due 2049

MILWAUKEE, June 16, 2026 (GLOBE NEWSWIRE) -- Fiserv, Inc. (NASDAQ: FISV) (the “Company”), a leading global provider of payments and financial services technology solutions, today announced the commencement of tender offers to purchase for cash any and all of the senior notes issued by the Company listed in the table below (collectively, the “Notes”). The tender offers (the “Offers”) are being made pursuant to the Offer to Purchase, dated June 16, 2026 (the “Offer to Purchase”).

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release

Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

Minghui Pharmaceutical Presents Compelling Phase I/II Results for MHB018A, a Novel Subcutaneous Anti-IGF-1R Antibody for Thyroid Eye Disease, in an Oral Presentation at ENDO...

MHB018A demonstrated outstanding clinical activity in both active and chronic thyroid eye diseaseAt 450 mg Q4W, MHB018A achieved a remarkable 81% proptosis response at...

BIFOX ENTERS INTO AGREEMENTS TO ACQUIRE THE 550 MILLION TONNE[1] BAYOVAR 9 PHOSPHATE ROCK PROJECT IN PERU POSITIONING BIFOX TO BECOME ONE OF THE...

SYDNEY, June 15, 2026 /PRNewswire/ -- Bifox Limited ("Bifox") is pleased to advise it has entered into two agreements with Fossal S.A.A ("Fossal"), to...

WESCAN GOLDFIELDS INC. ANNOUNCES CLOSING OF SECOND TRANCHE, UPSIZING AND EXTENSION OF PRIVATE PLACEMENT

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/SASKATOON, SK, June 15, 2026 /CNW/ - Wescan Goldfields Inc. (TSXV: WGF)...

RGC DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel...

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”), of the important June 23, 2026 lead plaintiff deadline.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStatements

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers